Clover Health Investments (CLOV) Common Equity (2019 - 2026)

Clover Health Investments (CLOV) has 8 years of Common Equity data on file, last reported at $339.4 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 1.0% year-over-year to $339.4 million; the trailing twelve-month figure through Mar 2026 stood at $339.4 million (up 1.0% YoY), and the FY2025 full-year result was $308.7 million, down 9.51% from the prior year.
• Common Equity for Q1 2026 stood at $339.4 million, up from $308.7 million in the prior quarter.
• Across five years, Common Equity topped out at $490.4 million in Q1 2022 and bottomed at $286.4 million in Q4 2023.
• The 5-year median for Common Equity is $339.4 million (2026), against an average of $347.0 million.
• The widest annual swing landed in 2022, when Common Equity surged 35.71%; it then plunged 34.11% in 2023.
• A 5-year view of Common Equity shows it stood at $356.9 million in 2022, then retreated by 19.75% to $286.4 million in 2023, then climbed by 19.12% to $341.1 million in 2024, then retreated by 9.51% to $308.7 million in 2025, then increased by 9.95% to $339.4 million in 2026.
• The last three Common Equity figures came in at $339.4 million (Q1 2026), $308.7 million (Q4 2025), and $340.9 million (Q3 2025), per Business Quant data.

Peer Comparison